Open Access
Article
Biomarkers in lung cancer
Alessandra Bearz1,Massimiliano Berretta1,Alessandro Cappellani1,Arben Lleshi1,Eleonora Berto1,Lucia Fratino1,Umberto Tirelli1
1
Department of Medical Oncology, CRO-IRCCS, National Cancer Institute, Aviano, PN, Italy. abearz@cro.it
DOI: 10.2741/E168 Volume 2 Issue 3, pp.1099-1104
Published: 01 June 2010
(This article belongs to the Special Issue Biochemical markers in biological fluids)
Abstract

Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.

Share and Cite
Alessandra Bearz, Massimiliano Berretta, Alessandro Cappellani, Arben Lleshi, Eleonora Berto, Lucia Fratino, Umberto Tirelli. Biomarkers in lung cancer. Frontiers in Bioscience-Elite. 2010. 2(3); 1099-1104.